Company intelligence / Profile preview

Altheus Therapeutics, Inc.

Oklahoma City, Oklahoma, United Statesolsfventures.com ↗

Ownership: Private
Employees: ~9
Development stage: Phase 2

Overview

Altheus completed a Phase 1 study of Zoenasa Rectal Gel with no serious adverse events reported. The company subsequently conducted a Phase 2 proof-of-concept clinical trial (ZA201) with 120 patients to evaluate the efficacy and safety of Zoenasa Rectal Gel versus mesalamine enema in patients with left-sided ulcerative colitis. The treatment portion of this trial was completed in February 2014.

Therapeutic areas: Gastroenterology
Modalities: Small moleculesfixed-dose combination therapy
Industry: Biotech

Drug pipeline

1 asset

ALTH12-2:4

Unknown

Beyond the preview

Go deeper on Altheus Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altheus Therapeutics, Inc..

Explore the full profile